Parallel Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-388
Closed -$16.3K 3531
2024
Q3
$16.3K Buy
388
+5
+1% +$208 ﹤0.01% 2199
2024
Q2
$15.6K Buy
383
+6
+2% +$239 ﹤0.01% 2115
2024
Q1
$15.6K Buy
377
+6
+2% +$251 ﹤0.01% 2112
2023
Q4
$15K Buy
371
+7
+2% +$267 ﹤0.01% 2109
2023
Q3
$14.3K Buy
364
+6
+2% +$239 ﹤0.01% 2024
2023
Q2
$14.6K Buy
358
+5
+1% +$206 ﹤0.01% 2003
2023
Q1
$14.8K Buy
353
+4
+1% +$168 ﹤0.01% 1968
2022
Q4
$15.2K Sell
349
-1,003
-74% -$42.6K ﹤0.01% 1842
2022
Q3
$52K Buy
1,352
+593
+78% +$25.3K ﹤0.01% 1242
2022
Q2
$32K Hold
759
﹤0.01% 1452
2022
Q1
$34K Hold
759
﹤0.01% 1461
2021
Q4
$37K Hold
759
﹤0.01% 1488
2021
Q3
$36K Hold
759
﹤0.01% 1427
2021
Q2
$37K Hold
759
﹤0.01% 1385
2021
Q1
$35K Hold
759
﹤0.01% 1333
2020
Q4
$36K Hold
759
﹤0.01% 1228
2020
Q3
$33K Hold
759
﹤0.01% 1238
2020
Q2
$30K Buy
759
+241
+47% +$9.72K ﹤0.01% 1235
2020
Q1
$18K Hold
518
﹤0.01% 1351
2019
Q4
$22K Buy
518
+133
+35% +$5.28K ﹤0.01% 1350
2019
Q3
$15K Buy
+385
New +$14.8K ﹤0.01% 1485

Other funds holding BME

Parallel Advisors's BME Position: Q4 2024 in Review

Parallel Advisors sold out of BlackRock Health Sciences Trust (BME) in Q4 2024, closing a stake of 388 shares — an estimated $16.3K sold.

Parallel Advisors first reported a position in BME in Q3 2019 and held it in 21 quarters. The position peaked at $52K in Q3 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2024.

  • Parallel Advisors reported no remaining BlackRock Health Sciences Trust position as of Q4 2024 after selling out during the quarter.
  • Parallel Advisors sold 388 BlackRock Health Sciences Trust shares in Q4 2024, an estimated $16.3K.
  • Parallel Advisors first reported a position in BlackRock Health Sciences Trust in Q3 2019 and held it in 21 quarters.
  • Parallel Advisors's BlackRock Health Sciences Trust position peaked at $52K in Q3 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2024.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.